CN1

N/A

Report date: 2025/03/06 17:57:57

Base Information

Drug NameCN1
Drug Alias NameCN-1
ClassificationBiologics
Mechanisms of ActionCytokines stimulantsCD4-positive T-lymphocytes stimulantsCD8-positive T-Lymphocytes stimulants
TargetsCytokines
Therapy Area/IndicationsSolid tumoursLymphoma, B-CellLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaAustriaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCuron Biopharmaceutical Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesCuron Biopharmaceutical (Australia) Co Pty LtdCuron Biopharmaceutical Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursLymphoma, B-Cell
Inactive IndicationsLymphoma

Other Information

ATC CodeN/A
Related LinksN/A